In this section, we describe the current leading hypotheses of AD, such as amyloid-β (Aβ) and tau protein dysfunction, neuroinflammation, blood-brain barrier (BBB) dysfunction, gut-brain axis, mitochondrial dysfunction, oxidative stress, and metabolism alterations. This evidence concerns the gene MAPT and Alzheimer disease.